Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cdc25C phosphatase is a key regulatory enzyme involved in cell cycle control, specifically the transition from G2 phase to mitosis. It functions as a dual-specificity phosphatase, primarily targeting cyclin-dependent kinases (CDKs) to promote cell division. Its activity is tightly regulated via phosphorylation and interactions with other proteins involved in checkpoint control. Dysregulation contributes directly to genomic instability and cancer development, making it an important therapeutic target.
Inhibition of phosphatase activity; preventing CDK1 dephosphorylation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell division cycle 25C phosphatase (CDC25C).